SAMMY-seq Chromatin Fractionation Without Crosslinking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for analyzing chromatin structure and accessibility, such as ChIP-seq and DamID, face limitations including reliance on crosslinking reagents, antibodies, and the need for large cell numbers, which can lead to technical biases and inability to detect early alterations in heterochromatin structure associated with diseases like laminopathies.
Innovation Solution
The SAMMY-seq technique involves high-throughput sequencing-based sequential analysis of chromatin fractions to map lamina-associated heterochromatin regions without crosslinking reagents or antibodies, allowing for genome-wide mapping of heterochromatin accessibility and identification of specific chromatin states, particularly in primary cells with limited sample amounts.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If ChIP-seq or DamID methods are used to map chromatin regions, then chromatin structure information can be obtained, but the methods require crosslinking reagents and antibodies which cause technical biases and artifacts
Solution Approach 1:
The patent extracts and removes the harmful crosslinking and antibody-based steps from the chromatin mapping process. Instead of using ChIP-seq or DamID which require crosslinking reagents and antibodies, the invention uses a simplified protocol that directly profiles chromatin accessibility through sequencing of naked DNA, eliminating the sources of technical artifacts while preserving the ability to detect chromatin structure changes
Solution Approach 2:
The patent replaces the chemical crosslinking mechanism with a physical/chemical extraction approach. Instead of using formaldehyde crosslinking to fix protein-DNA interactions, the method uses controlled DNA extraction from chromatin fractions followed by sonication and sequencing, substituting chemical fixation with a cleaner extraction and fragmentation protocol that avoids artifacts
2Measurement precision
If conventional chromatin analysis methods are used, then chromatin states can be identified, but large numbers of cells are required which prevents analysis of rare cell populations
Solution Approach 1:
The patent segments the chromatin into distinct fractions (S1-S4) based on accessibility, allowing sequential analysis of different chromatin states from a single limited sample. This segmentation enables comprehensive profiling of heterochromatin and euchromatin regions without requiring separate large-scale samples for each chromatin state analysis
Solution Approach 2:
The patent changes the accessibility parameter of chromatin regions through sequential extraction with increasing stringency (S1 to S4 fractions). By varying the extraction conditions and analyzing DNA from each fraction, the method can identify different chromatin states from the same limited cell population, enabling analysis of rare cells that would be insufficient for conventional methods
3Measurement precision
If sequential chromatin fractionation is performed to detect early alterations, then sensitivity to early changes is improved, but the protocol complexity increases
Solution Approach 1:
The patent divides chromatin into four sequential fractions (S1-S4) with increasing compaction, where S1 contains most accessible regions and S4 contains the most compact heterochromatin. This segmentation allows detection of early chromatin alterations by comparing the distribution of genomic regions across fractions, providing enhanced sensitivity while maintaining a relatively simple sequential extraction protocol
Solution Approach 2:
The patent performs preliminary sequential fractionation of chromatin into distinct accessibility-based compartments before sequencing. By pre-separating chromatin into S1-S4 fractions that represent different compaction states, the method prepares the sample in advance to maximize sensitivity for detecting early structural alterations, allowing subsequent sequencing to reveal changes that would be obscured in bulk analysis
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
SAMMY-seq provides robust, quantitative data on chromatin accessibility and heterochromatin changes, enabling early detection of alterations in diseases like Hutchinson-Gilford progeria syndrome, overcoming limitations of existing techniques by avoiding chemical modifications and antibody reliance, and allowing analysis of rare cell populations.
Implementation Method 1
performing a salt-based sequential fractionation of isolated genetic material to separate genomic regions on the basis of their accessibility
Implementation Method 2
sonicating the extracted nucleic acids such that chromatin is fragmented to have comparable profile of different fractions
Data Source
Figure 1a~1c
Figure 2a~2c
Figure 3a~3c
AI summary
The present invention relates to an in vitro method for analyzing chromosomal nucleic acids, the method comprising: a) providing at least one isolated cell that comprises genetic material and b) performing a salt-based sequential fractionation of genetic material to separate genomic regions on the basis of their accessibility and obtain chromatin fractions and c) extracting the nucleic acids from the above chromatin fractions and d) optionally sonicating the extracted nucleic acids such that chromatin is fragmented to have comparable profile of different fractions and e) sequencing the extracted nucleic acids of step c) or the sonicated nucleic acid of step d).